市场调查报告书
商品编码
1434219
大麻市场:型态、产品类型、化合物、来源、分销管道、应用 - 全球预测 2024-2030Cannabis Market by Form (Concentrated Oil, Cream, Food Additive), Product Type (Concentrates, Flower, leaves), Compound, Source, Distribution Channel, Application - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计2023年大麻市场规模为327.3亿美元,预计2024年将达417.7亿美元,2030年将达到1872.4亿美元,复合年增长率为28.29%。
大麻全球市场
主要市场统计 | |
---|---|
基准年[2023] | 327.3亿美元 |
预测年份 [2024] | 417.7亿美元 |
预测年份 [2030] | 1872.4亿美元 |
复合年增长率(%) | 28.29% |
大麻市场上的大麻衍生产品包括但不限于干燥花、浓缩物、食用品、外用品和大麻素,例如 THC(四氢大麻酚)和 CBD(大麻二酚)。大麻产业服务于各种最终用途领域,包括医疗保健、製药、个人护理、食品和饮料等。在医学领域,大麻用于缓解与慢性疼痛、癌症、癫痫和多发性硬化症等疾病相关的症状。大麻的休閒用途提供了酒精和烟草等传统休閒产品的替代品。大麻市场范围包括全球和区域销售、产品创新、供应链管理、监管状况等。大麻市场成长的主要驱动力是日益合法化、扩大药用用途以及越来越多地采用大麻作为消费品。此外,遗传学和种植技术的进步以及大麻相关调查投资的增加也有助于市场扩张。大麻市场的最新潜在机会包括快速成长的 CBD 市场,特别是在健康和保健领域,整合区块链以提高供应链透明度,以及探索新的输送系统以提高生物有效性。创新在大麻注入产品(例如饮料和偏好产品)以及根据个人基因特征量身定制的个人化大麻药物领域尤其活跃。此外,为了吸引具有环保意识的消费者,我们将引入环保的种植和加工方法,并投资于消费者教育,以克服耻辱并告知负责任的使用。利用人工智慧和机器学习对种植和消费者偏好进行预测分析预计将推动市场成长。然而,不同司法管辖区存在复杂的监管障碍、高昂的合规成本以及大麻使用持续存在的污名化。此外,缺乏标准化的剂量和消费方法、黑市营运商的激烈竞争以及银行和金融服务的障碍限制了市场潜力。
区域洞察
美洲拥有一个复杂且快速扩张的大麻市场,各州的法律体制略有不同,联邦层级的法律框架几乎没有变化。消费者的需求因地区和人口而异,趋势显示对药用大麻产品和合法州休閒大麻产品的需求显着增加。顾客的购买行为显示出对偏好和电子烟的强烈趋势。虽然新专利的竞争加剧,特别是在种植技术和大麻素合成方面,但一些州已经开始了调查计画。在亚太地区,中国和印度涉足大麻市场主要集中于生产大麻,这是一种非精神活性品种。中国是大麻衍生产品(包括纺织品和大麻二酚(CBD)萃取物)的最大生产国之一,但国内消费受到严格监管。另一方面,印度是一个有着古老文化联繫的新兴市场,但仍受到严格监管,并显示出在医学研究和阿育吠陀方面的应用潜力。在欧洲,大麻的监管环境较为分散,德国、义大利和荷兰等国家在患者准入和产品多样性方面处于领先地位,并且总体上正在走向更加开放的製药市场。我是。欧盟客户的购买行为反映出人们对大麻潜在医疗益处的认识和接受程度不断提高,从而导致对药用大麻产品和相关研究的投资增加。
FPNV定位矩阵
FPNV 定位矩阵对于评估大麻市场至关重要。我们检视与业务策略和产品满意度相关的关键指标,以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估,供应商被分为四个成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对大麻市场供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献,以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外,该分析还提供了对该行业竞争特征的宝贵见解,包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更明智的决策并制定有效的策略,从而在市场上获得竞争优势。
1-市场渗透率:提供有关主要企业所服务的市场的全面资讯。
2-市场开拓:我们深入研究利润丰厚的新兴市场,并分析它们在成熟细分市场中的渗透率。
3- 市场多元化:提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。
4-竞争力评估与资讯:对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。
5- 产品开发与创新:提供对未来技术、研发活动和突破性产品开发的见解。
1-大麻市场的市场规模和预测是多少?
2-大麻市场预测期内需要考虑投资的产品、细分市场、应用和领域有哪些?
3-大麻市场的技术趋势和法律规范是什么?
4-大麻市场主要供应商的市场占有率是多少?
5-进入大麻市场的适当型态或策略手段是什么?
[180 Pages Report] The Cannabis Market size was estimated at USD 32.73 billion in 2023 and expected to reach USD 41.77 billion in 2024, at a CAGR 28.29% to reach USD 187.24 billion by 2030.
Global Cannabis Market
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 32.73 billion |
Estimated Year [2024] | USD 41.77 billion |
Forecast Year [2030] | USD 187.24 billion |
CAGR (%) | 28.29% |
The cannabis market products derived from cannabis include but are not limited to dry flowers, concentrates, edibles, topicals, and cannabinoids such as THC (tetrahydrocannabinol) and CBD (cannabidiol). The cannabis industry serves various end-use sectors, such as healthcare, pharmaceuticals, personal care, and food & beverages. In the medical sector, cannabis is prescribed to alleviate symptoms associated with chronic pain, cancer, epilepsy, and multiple sclerosis, among others. The recreational use of cannabis provides an alternative to traditional leisure substances such as alcohol and tobacco. The scope of the cannabis market includes global and regional sales, product innovation, supply chain management, and regulatory landscapes. Cannabis market growth is predominantly driven by increasing legalization, growing medicinal applications, and the rising adoption of cannabis as a consumer good. Furthermore, advancements in genetics and cultivation technology, and increasing investment in cannabis-related research, contribute to the market's expansion. The latest potential opportunities within the cannabis market include the burgeoning CBD market, especially in the health and wellness sector, the integration of blockchain for supply chain transparency, and the exploration of new delivery systems to enhance bioavailability. Innovations are particularly thriving in areas of cannabis-infused products, such as beverages and edibles, as well as personalized cannabis medicines tailored to individual genetic profiles. Furthermore, implementing eco-friendly cultivation and processing methods to appeal to environmentally-conscious consumers and investing in consumer education to overcome stigma and inform about responsible use. Leveraging AI and machine learning for predictive analytics in cultivation and consumer preferences is expected to propel market growth. However, complex regulatory hurdles across different jurisdictions, high compliance costs, and the persistent stigmatization of cannabis use. In addition, the lack of standardized dosing and methods of consumption, significant competition from black-market operators, and hurdles in banking and financial services pose limitations to the market's potential.
Regional Insights
The Americas represents a complex and rapidly expanding cannabis market, differing minimally at the federal level but with nuanced legal frameworks across the states. Consumer needs vary significantly by region and demographics, with trends showing a substantial increase in demand for both medicinal and, in legal states, recreational cannabis products. Customer purchasing behavior demonstrates a strong inclination towards edibles and vapes. Several states have initiated research programs while the race for new patents is intense, particularly in cultivation tech and cannabinoid synthesis. In APAC, China's and India's involvement in the cannabis market is predominantly focused on the production of hemp, a non-psychoactive variety of cannabis. China is one of the largest producers of hemp-derived products such as textiles and cannabidiol (CBD) extracts, though consumption within the country remains strictly controlled. Meanwhile, India presents a nascent market with ancient cultural ties to cannabis, and while still heavily regulated, it shows potential for medical cannabis research and Ayurvedic applications. In Europe, the regulatory landscape for cannabis is fragmented but generally moving towards more open medicinal markets, with countries such as Germany, Italy, and the Netherlands leading in patient access and product diversity. The EU's customer purchasing behavior reflects a growing awareness and acceptance of the potential medical benefits of cannabis, leading to increased investment in pharmaceutical cannabis products and related research.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Cannabis Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Cannabis Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Cannabis Market, highlighting leading vendors and their innovative profiles. These include Acreage Holdings, Aphria, Inc., Aurora Cannabis Inc., Cannabis Science Inc., Canopy Growth Corporation, Chronos Group Inc., Cresco Labs, Inc., Curaleaf Holdings, Inc., CV Sciences Inc., EcoGen Biosciences, Elixinol Wellness Limited, Extractas Bioscience, Folium Europe B.V., Green Thumb Industries Inc., Lexaria Bioscience Corp., Medical Marijuana, Inc., MediPharm Labs Inc., Organigram Holdings Inc., Peace Naturals Project Inc., PharmaHemp d.o.o., StenoCare A/S, The Seed Cellar, and Tikun Olam.
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Cannabis Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Cannabis Market?
3. What are the technology trends and regulatory frameworks in the Cannabis Market?
4. What is the market share of the leading vendors in the Cannabis Market?
5. Which modes and strategic moves are suitable for entering the Cannabis Market?